JPMorgan Chase & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.89B | Sell |
|
|||||
|
2025
Q2 | $4.81B | Sell |
|
|||||
|
2025
Q1 | $6.59B | Buy |
|
|||||
|
2024
Q4 | $5.43B | Buy |
|
|||||
|
2024
Q3 | $4.03B | Buy |
|
|||||
|
2024
Q2 | $3.1B | Sell |
|
|||||
|
2024
Q1 | $4.82B | Sell |
|
|||||
|
2023
Q4 | $4.62B | Sell |
|
|||||
|
2023
Q3 | $5.61B | Sell |
|
|||||
|
2023
Q2 | $6.61B | Buy |
|
|||||
|
2023
Q1 | $6.7B | Sell |
|
|||||
|
2022
Q4 | $7.1B | Sell |
|
|||||
|
2022
Q3 | $7.07B | Buy |
|
|||||
|
2022
Q2 | $7.53B | Buy |
|
|||||
|
2022
Q1 | $6.86B | Buy |
|
|||||
|
2021
Q4 | $5.72B | Buy |
|
|||||
|
2021
Q3 | $5.06B | Buy |
|
|||||
|
2021
Q2 | $5.57B | Buy |
|
|||||
|
2021
Q1 | $4.8B | Buy |
|
|||||
|
2020
Q4 | $4.49B | Buy |
|
|||||
|
2020
Q3 | $3.98B | Buy |
|
|||||
|
2020
Q2 | $3.8B | Buy |
|
|||||
|
2020
Q1 | $3.37B | Buy |
|
|||||
|
2019
Q4 | $3.3B | Buy |
|
|||||
|
2019
Q3 | $1.81B | Buy |
|
|||||
|
2019
Q2 | $1.12B | Buy |
|
|||||
|
2019
Q1 | $814M | Sell |
|
|||||
|
2018
Q4 | $971M | Sell |
|
|||||
|
2018
Q3 | $1.22B | Sell |
|
|||||
|
2018
Q2 | $1.26B | Buy |
|
|||||
|
2018
Q1 | $1.43B | Sell |
|
|||||
|
2017
Q4 | $1.5B | Buy |
|
|||||
|
2017
Q3 | $1.42B | Sell |
|
|||||
|
2017
Q2 | $1.26B | Sell |
|
|||||
|
2017
Q1 | $1.35B | Sell |
|
|||||
|
2016
Q4 | $1.69B | Sell |
|
|||||
|
2016
Q3 | $1.77B | Sell |
|
|||||
|
2016
Q2 | $2.85B | Buy |
|
|||||
|
2016
Q1 | $2.12B | Buy |
|
|||||
|
2015
Q4 | $2.23B | Sell |
|
|||||
|
2015
Q3 | $1.99B | Sell |
|
|||||
|
2015
Q2 | $2.51B | Buy |
|
|||||
|
2015
Q1 | $2.31B | Buy |
|
|||||
|
2014
Q4 | $1.99B | Sell |
|
|||||
|
2014
Q3 | $1.91B | Sell |
|
|||||
|
2014
Q2 | $2.1B | Sell |
|
|||||
|
2014
Q1 | $2.29B | Buy |
|
|||||
|
2013
Q4 | $2.22B | Sell |
|
|||||
|
2013
Q3 | $2.04B | Buy |
|
|||||
|
2013
Q2 | $1.55B | Buy |
|